Intro

This chapter explores the significant effects of anti-obesity drugs, focusing on Zepbound and its active compound terzepatide. The discussion also covers the complex naming process for pharmaceuticals and how these developments are influencing Eli Lilly's prominence in the industry.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app